Barnik Holdings enters 2025 with a dynamic portfolio of companies driving innovation across the life science landscape. Our focus remains on value adding support to our portfolio companies as they translate groundbreaking research into impactful therapies and solutions. This year promises exciting developments as our companies advance their clinical programs, expand into new markets, and bring innovative products to patients worldwide.

Barnik Holdings offers investors diversified exposure to a curated portfolio of high-growth Swedish life science companies. As the holding company for the entire Barnik Invest Group, we provide access to a range of exciting opportunities across various therapeutic areas and technologies. Backed by a team of seasoned professionals with deep industry expertise, we rigorously identify and nurture promising companies. By investing in Barnik Holdings, you gain access to our entire portfolio, benefit from our strategic guidance and extensive network, partner with us to drive value creation and deliver superior returns.